Recruiting

Observational Study

Sponsor:

Boston Medical Center

Code:

NCT00898235

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

clonality analysis

polymerase chain reaction

protein analysis

biologic sample preservation procedure

laboratory biomarker analysis

Study Details

Brief summary:

RATIONALE: Collecting and storing samples of blood, urine, tissue and data from patients with amyloid diseases to test in the laboratory may help the study of this disease in the future.

PURPOSE: This research study is collecting samples from patients with amyloid diseases

Conditions

Multiple Myeloma

Study ID

NCT00898235

Start date

Jan, 2000

Status verified date

Nov, 2025

Completion date

Dec, 2040

Anticipated

Primary completion date

Dec, 2040

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

DISEASE CHARACTERISTICS:

  • Diagnosis or suspicion of amyloidosis

PATIENT CHARACTERISTICS:

  • Referred to the Amyloid Treatment and Research Center at Boston University Medical Center

PRIOR CONCURRENT THERAPY:

  • Not specified

Exclusion Criteria:

None

Study Design

Enrollment

10000 participants

Anticipated

Interventions and Outcome Measures

Interventions

clonality analysis

analyze clonality

polymerase chain reaction

analyze polymerase chain reaction

protein analysis

analyze protein

biologic sample preservation procedure

preserve biologic samples

laboratory biomarker analysis

analyze laboratory biomarkers

fluorescence spectroscopy

perform fluorescence spectroscopy on specimens

quality-of-life assessment

assess quality of life at each follow-up for life

Primary outcome measure

  • Establish a repository to promote biochemical research [ Time Frame: life of study ]

Central Contacts and Locations

Central contacts

Locations

Boston University Cancer Research Center

Recruiting

Boston, Massachusetts, United States, 02118

Contacts

Clinical Trials Office - Boston University Cancer Research Cen

617-638-8265

More Information

Sponsor

Boston Medical Center

Last update posted

Dec 1, 2025

Last verified

Nov, 2025

Keywords

  • primary systemic amyloidosis

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Boston Medical Center on 2025-12-01.